IN-DEPTH FOCUS

Bioprocessing / Bioproduction In-Depth Focus 2024

This in-depth focus features articles on bioreactor size, as well as bioprocess development and manufacturing of bioconjugated products.

Bioprocessing and bioproduction IDF

  • Unlocking the potential of biologics production: a comprehensive exploration
    Different types of biologics require different sized bioreactors and different manufacturing approaches, as Sridevi Khambhampaty, Vice President at Syngene International Limited, elucidates.
  • Bioconjugation of antibody-drug conjugates: the past, present and future
    Development of antibody-drug conjugates (ADCs) has experienced significant growth over the past two decades. Here, Parviz Shamlou, Senior Vice President, Science and Technology at Abzena, explores how the evolution of bioconjugation technology is leading to therapeutic advancements in oncology and beyond.

 

Interested in bioprocessing/bioproduction? Register your details to download this exclusive In-Depth Focus